Dr. David W. Brandli

Eric S. Rovner, M.D. is the director of the section of voiding dysfunction, female urology, and urodynamics in the Department of Urology at MUSC. He has a highly specialized clinical practice within urology and sees mostly patients with complex voiding problems including urinary incontinence, vaginal prolapse, urinary fistulae, and neurogenic bladder dysfunction. Dr. Rovner is a board-certified member of the American Urological Association, fellow of the American College of Surgeons, as well as a member of the American Association of GU Surgeons, Society of Pelvic Surgeons, Society of University Urologists, Societe Internationale D'Urologie, and the Society for Urodynamics, Female Urology, and Urogenital Reconstruction (SUFU), among others. Dr. Rovner has served on several committees for the WHO international consultation on incontinence, and served as a member of the American Urological Association's stress incontinence surgery guidelines committee. He is a past president of SUFU, past chair of the young urologists committee of the AUA and past member of the AUA education council as well as the ABU/AUA written and oral examination committees. Dr. Rovner's research interests include the study of voiding dysfunction, incontinence, overactive bladder, neurourology, and urodynamics. He has held several visiting professorships nationally and internationally, and is the author of over 150 peer-reviewed scientific articles, monographs, and book chapters on these topics as well as a book on urinary incontinence and urodynamics. He has been an invited speaker on numerous occasions throughout the United States and the world and has been the principal or co-investigator on multiple grants. Dr. Rovner is highly rated in 14 conditions, according to our data. His clinical expertise encompasses Urinary Incontinence, Stress Urinary Incontinence, Frequent or Urgent Urination, Bladder Reconstruction, and Reconstructive Urology Surgery. Dr. Rovner is currently accepting new patients.

Eric Wallen is Professor and Chair of the Urology Department at MUSC. His clinical work is focused on patient-centered delivery of care to patients with urologic malignancies such as prostate, kidney, bladder, and testicular cancer. He is an expert in robotic surgery with over 20 years of experience. Prior to assuming the chair position at MUSC he was Professor, Vice-Chair of Education, Program Director, and Medical Director of System Supply Chain at UNC Chapel Hill. He graduated from Yale College with a degree in political science and received his MD from the University of California, Los Angeles. His urologic training was completed at Stanford University. Dr. Wallen is highly rated in 18 conditions, according to our data. His clinical expertise encompasses Renal Cell Carcinoma (RCC), Bladder Cancer, Prostate Cancer, Cystectomy, and Nephrectomy. Dr. Wallen is currently accepting new patients.

Dr. Stephen Savage graduated from Dartmouth College in 1989, completed medical school at the Columbia University College of Physicians and Surgeons in 1993 and received his urology training at the Mount Sinai Medical Center in New York City in 1999. He went on to receive fellowship training in minimally invasive urology at the Cleveland Clinic Foundation. Following completion of his fellowship, he was the director of minimally invasive urology at Mount Sinai Medical Center from 2000 through 2002 when he joined the staff at Memorial Sloan Kettering Cancer Center to help develop their minimally invasive urologic oncology program. He joined the staff at the Medical University of South Carolina and Hollings Cancer Center in 2004 as an associate professor of urology and director of minimally invasive urology.Dr. Savage has interest and expertise in the minimally invasive treatment of urologic cancers including prostate, kidney, bladder and testicular. He has performed complex minimally invasive surgeries since 1999 and continues to utilize these techniques to benefit patients in the approach to urologic cancer. He has published numerous articles related to urologic cancers and participates in many multidisciplinary clinical trials. He is the vice chairman of the Department of Urology and is the director of the urologic oncology fellowship at MUSC. Dr. Savage is highly rated in 34 conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Ureterocele, Nephrectomy, and Reconstructive Urology Surgery. Dr. Savage is currently accepting new patients.